Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer and the Microbiome—Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy
Vyara Matson, Carolina Soto Chervin, Thomas F. Gajewski
Gastroenterology (2020) Vol. 160, Iss. 2, pp. 600-613
Open Access | Times Cited: 280

Showing 1-25 of 280 citing articles:

Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments
Zhennan Yuan, Yingpu Li, Sifan Zhang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 362
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
Yuting Lu, Xiangliang Yuan, Miao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 279
Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers
Jinzhu Mao, Dongxu Wang, Junyu Long, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 12, pp. e003334-e003334
Open Access | Times Cited: 186
Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy
Despoina Chrysostomou, Lauren A. Roberts, Julian R. Marchesi, et al.
Gastroenterology (2022) Vol. 164, Iss. 2, pp. 198-213
Open Access | Times Cited: 134
Fusobacterium nucleatum and cancer
Tamar Alon‐Maimon, Ofer Mandelboim, Gilad Bachrach
Periodontology 2000 (2022) Vol. 89, Iss. 1, pp. 166-180
Open Access | Times Cited: 100
Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora
Hourieh Sadrekarimi, Zhanna R. Gardanova, Morteza Bakhshesh, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 79
5-hydroxytryptamine produced by enteric serotonergic neurons initiates colorectal cancer stem cell self-renewal and tumorigenesis
Pingping Zhu, Tiankun Lu, Zhenzhen Chen, et al.
Neuron (2022) Vol. 110, Iss. 14, pp. 2268-2282.e4
Closed Access | Times Cited: 75
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Andrew Maltez Thomas, Marine Fidelle, Bertrand Routy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 583-603
Closed Access | Times Cited: 73
Acetyltransferase fromAkkermansia muciniphilablunts colorectal tumourigenesis by reprogramming tumour microenvironment
Yi Jiang, Yuejie Xu, Chang Zheng, et al.
Gut (2023) Vol. 72, Iss. 7, pp. 1308-1318
Closed Access | Times Cited: 72
The Rise of Gastrointestinal Cancers as a Global Phenomenon: Unhealthy Behavior or Progress?
Sílvia Rodrigues Jardim, Lucila Marieta Perrotta de Souza, Heitor Siffert Pereira de Souza
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3640-3640
Open Access | Times Cited: 67
Advancing CAR T cell therapy through the use of multidimensional omics data
Jingwen Yang, Yamei Chen, Ying Jing, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 4, pp. 211-228
Closed Access | Times Cited: 65
Heart–gut microbiota communication determines the severity of cardiac injury after myocardial ischaemia/reperfusion
Jinxuan Zhao, Zhang Qi, Wei Cheng, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 6, pp. 1390-1402
Open Access | Times Cited: 59
Recent insights into the nutritional immunomodulation of cancer‐related microRNAs
Teslime Özge Şahin, Birsen Yılmaz, Neslihan Yeşilyurt, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 10, pp. 4375-4397
Open Access | Times Cited: 58
Gut microbiota and risk of five common cancers: A univariable and multivariable Mendelian randomization study
Zixin Wei, Biying Yang, Tiantian Tang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 9, pp. 10393-10405
Open Access | Times Cited: 57
Causal effects of gut microbiota on the risk of chronic kidney disease: a Mendelian randomization study
Mingli Luo, Jiahao Cai, Shulu Luo, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 47
Biotherapy Using Probiotics as Therapeutic Agents to Restore the Gut Microbiota to Relieve Gastrointestinal Tract Inflammation, IBD, IBS and Prevent Induction of Cancer
Divakar Dahiya, Poonam Singh Nee Nigam
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5748-5748
Open Access | Times Cited: 46
Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies
Jindong Xie, Manqing Liu, Xinpei Deng, et al.
iMeta (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 31
Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy
Yunwei Yang, Yaping An, Yue Dong, et al.
EBioMedicine (2024) Vol. 100, pp. 104967-104967
Open Access | Times Cited: 19
Bifidobacterium modulation of tumor immunotherapy and its mechanism
Bo Pei, Shixuan Peng, Chuying Huang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 5
Open Access | Times Cited: 18
Gut microbiome affects the response to immunotherapy in non‐small cell lung cancer
Shengnan Ren, Lingxin Feng, Haoran Liu, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 14, pp. 1149-1163
Open Access | Times Cited: 17
New insights into natural products that target the gut microbiota: Effects on the prevention and treatment of colorectal cancer
Lu Lu, Jiahuan Dong, Yujing Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 61
Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects
Jing Li, Aihua Zhang, Fangfang Wu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 56
Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science
Kentaro Inamura, Tsuyoshi Hamada, Susan Bullman, et al.
Gut (2022) Vol. 71, Iss. 10, pp. 2107-2122
Open Access | Times Cited: 54
Gut microbiome in gastrointestinal cancer: a friend or foe?
Yang Liu, Yoshifumi Baba, Takatsugu Ishimoto, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 10, pp. 4101-4117
Open Access | Times Cited: 51
The Role of The Tumor Microbiome in Tumor Development and Its Treatment
Yan Chen, Fahong Wu, Pengqiang Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 48
Page 1 - Next Page

Scroll to top